Chlamydia trachomatis in cervical and vaginal swabs and urine specimens from women undergoing termination of pregnancy

International Journal of STD and AIDS

Volumn 17, Issue 7, 2006, Pages 443-447

  Renton, A ^a   Thomas, B M ^b   Gill, S ^c   Lowndes, C ^b   Taylor Robinson, D ^d   Patterson, K ^d  

^a UNIVERSITY OF EAST LONDON   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c ST MARY S HOSPITAL   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Assay; Chlamydia infections; Endocervical swabs; Ligase chain reaction; Urine

Indexed keywords

DOXYCYCLINE; METRONIDAZOLE;

ADOLESCENT; ADULT; ARTICLE; BACTERIUM DETECTION; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; FOLLOW UP; HUMAN; IMMUNOASSAY; LIGASE CHAIN REACTION; MAJOR CLINICAL STUDY; NUCLEIC ACID AMPLIFICATION; POLYMERASE CHAIN REACTION; PREGNANCY TERMINATION; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; URINE; UTERINE CERVIX; VAGINA;

ABORTION, INDUCED; CERVIX UTERI; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; DNA, BACTERIAL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; LIGASE CHAIN REACTION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; URINE; VAGINA;

EID: 33745905917     PISSN: 09564624     EISSN: 09564624     Source Type: Journal    
DOI: 10.1258/095646206777689053     Document Type: Article

References (21)

1. Simms I, Catchpole M, Brugha R, Rogers P, Mallinson H, Nicoll A. Epidemiology of genital Chlamydia trachomatis in England and Wales. Genitourin Med 1997;73:122-6
2. Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996;334:1362-6
3. Mallinson H, Hopwood J, Skidmore S, Fenton K, Phillips C, Jones I. Provision of chlamydia testing in a nationwide service offering termination of pregnancy: with data capture to monitor prevalence of infection. Sex Transm Infect 2002;78:416-21
4. Underhill G, Hewitt G, McLean L, Randall S, Tobin J, Harindra V. Who has chlamydia? The prevalence of genital tract Chlamydia trachomatis within Portsmouth and South East Hampshire, UK. J Fam Plan Reprod Health Care 2003;29:17-20
5. Blackwell AL, Thomas PD, Wareham K, Emery SJ. Health gains from screening for infection of the lower genital tract in women attending for termination of pregnancy. Lancet 1993;342:206-10
6. Chief Medical Officer's Expert Advisory Group. Main Report of the CMO's Expert Advisory Group on Chlamydia trachomatis. London: Department of Health, 1998
7. Taylor-Robinson D. Evaluation and comparison of tests to diagnose Chlamydia trachomatis genital infections. Hum Reprod 1997;12(11 Suppl):113-20
8. Taylor-Robinson D, Thomas BJ. Laboratory techniques for the diagnosis of chlamydial infections. Genitourin Med 1991;67:256-66
9. Sellors JW, Mahony JB, Jang D, et al. Comparison of cervical, urethral, and urine specimens for the detection of Chlamydia trachomatis in women. J Infect Dis 1991;164:205-8
10. Hay PE, Thomas BJ, Horner PJ, Macleod E, Renton AM, Taylor-Robinson D. Chlamydia trachomatis in women: the more you look, the more you find. Genitourin Med 1994;70:97-100
11. Watson EJ, Templeton A, Russell I, et al. The accuracy and efficacy of screening tests for Chlamydia trachomatis: a systematic review. J Med Microbiol 2002;51:1021-31
12. Horner PJ, Crowley T, Leece J, Hughes A, Davey Smith G, Caul EO. Chlamydia trachomatis infection and the menstrual cycle. Lancet 1998;351:341-2
13. Moller JK, Andersen B, Olefsen F, Lignell T, Ostergaard L. Impact of menstrual cycle on the diagnostic performance of LCR, TMA, and PCE for detection of Chlamydia trachomatis in home obtained and mailed vaginal flush and urine samples. Sex Transm Infect 1999;75:228-30
14. Jensen IP, Thorsen P, Moller BR. Sensitivity of ligase chain reaction assay of urine from pregnant women for Chlamydia trachomatis. Lancet 1997;349:329-30
15. Thomas BJ, Pierpoint T, Taylor-Robinson D, Renton AM. Sensitivity of the ligase chain reaction assay for detecting Chlamydia trachomatis in vaginal swabs from women who are infected at other sites. Sex Transm Infect 1998;74:140-1
16. Thomas BJ, Pierpoint T, Taylor-Robinson D, Renton AM. Qualitative and quantitative aspects of the ligase chain reaction assay for Chlamydia trachomatis in genital tract samples and urines. Int J STD AIDS 2001;12:589-94
17. LaMontagne DS, Catchpole M, Fenton K. British Chief Medical Officer recommendations for genital chlamydial screening may not be applicable outside the UK. J Med Screen 2003;10:210-11
18. Pimenta JM, Catchpole M, Rogers PA, et al. Opportunistic screening for genital chlamydial infection.1: acceptability of urine testing in primary and secondary health settings. Sex Transm Infect 2003;79:16-21
19. Harindra V, Underhill G, Tobin JM. Screening for genital chlamydia infection: DNA amplification techniques should be the test of choice. Int J STD AIDS 2003;14:723-6
20. Gray J, Huengsberg M, Mann M, et al. A multidisciplinary approach to chlamydia screening in women undergoing termination of pregnancy: how well are we doing? Int J STD AIDS 2003;14:287-8
21. LaMontagne DS, Pimenta JM, Fenton KA, Mallinson H, Hopwood J. Management of genital chlamydial infections at termination of pregnancy services in England and Wales: where are we now? Br J Obstet Gynaecol 2004;111:1408-12